Acute spinal cord lesions result in dramatic changes in neuronal function. Studies have shown that the peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, has neuroprotective properties. The effect of rosiglitazone after acute spinal cord injury was examined in the present study. Rats were subjected to laminectomy only; laminectomy with spinal cord contusion injury; laminectomy with contusion injury plus 30 mg/kg body weight methylprednisolone administered 5 min after surgery; or laminectomy with contusion injury plus 2 mg/kg body weight rosiglitazone administered intra-peritoneally 5 min, 6 h and 24 h after surgery. Both drugs increased neurotrophin gene and protein expression 24 h after injury compared with injured rats without drug treatment. Rosiglitazone increased neurotrophin expression at 7 days to a greater extent than methylprednisolone. Early functional recovery was observed in rats treated with rosiglitazone. The greater increase in rosiglitazone-induced nerve growth factor expression soon after injury could explain, at least in part, the improved recovery of motor function compared with methylprednisolone or saline.
JonesTBMcDanielEEPopovichPG: Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des2005; 11: 1223–1236.
5.
LehrkeMLazarMA: The many faces of PPARγ. Cell2005; 123: 993–999.
6.
TolmanKGChandramouliJ: Hepatotoxicity of the thiazolidinediones. Clin Liver Dis2003; 7: 369–379.
7.
KiaeiMKipianiKChenJ: Peroxisome proliferator-activated receptor-γ agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol2005; 191: 331–336.
8.
DehmerTHenekaMTSastreM: Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation. J Neurochem2004; 88: 494–501.
9.
VictorNAWanderiEWGamboaJ: Altered PPARγ expression and activation after transient focal ischemia in rats. Eur J Neurosci2006; 24: 1653–1663.
10.
YiJHParkSWBrooksN: PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res2008; 1244: 164–172.
11.
McTigueDMTripathiRWeiP: The PPARγ agonist pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury. Exp Neurol2007; 205: 396–406.
12.
ParkSWYiJHMiranpuriG: Thiazolidinedione class of peroxisome proliferator-activated receptor γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther2007; 320: 1002–1012.
13.
LiuNHanSLuPH: Upregulation of annexins I, II, and V after traumatic spinal cord injury in adult rats. J Neurosci Res2004; 77: 391–401.
14.
BassoDMBeattieMSBresnahanJC: Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol1996; 139: 244–256.
15.
TureyenKBrooksNBowenK: Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem2008; 105: 1313–1324.
16.
Levi-MontalciniRHamburgerV: Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool1951; 116: 321–361.
17.
WidenfalkJLundströmerKJubranM: Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci2001; 21: 3457–3475.
18.
QinDXZouXLLuoW: Expression of some neurotrophins in the spinal motoneurons after cord hemisection in adult rats. Neurosci Lett2006; 410: 222–227.
19.
RocamoraNPascualMAcsàdyL: Expression of NGF and NT3 mRNAs in hippocampal interneurons innervated by the GABAergic septohippocampal pathway. J Neurosci1996; 16: 3991–4004.
20.
DellerTHaasCAFreimanTM: Lesion-induced axonal sprouting in the central nervous system. Adv Exp Med Biol2006; 557: 101–121.
21.
BakhitCArmaniniMWongWLT: Increase in nerve growth factor-like immunoreactivity and decrease in choline acetyltransferase following contusive spinal cord injury. Brain Res1991; 554: 264–271.
22.
BennettADTaglialatelaGPerez-PoloR: NGF levels decrease in the spinal cord and dorsal root ganglia after spinal hemisection. Neuroreport1999; 10: 889–893.
23.
OudegaMHaggT: Nerve growth factor promotes regeneration of sensory axons into adult rat spinal cord. Exp Neurol1996; 140: 218–229.
24.
MurakamiYFurukawaSNittaA: Accumulation of NGF protein at both rostral and caudal stumps in the transected rat spinal cord. J Neurol Sci2002; 198: 63–69.
25.
BeattieMSHarringtonAWLeeR: ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron2002; 36: 375–386.
26.
BrownARicciMJWeaverLC: NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the rat. Exp Neurol205: 283–286.
27.
LiXLZhangWZhouX: Temporal changes in the expression of some neurotrophins in spinal cord transected adult rats. Neuropeptides2007; 41: 135–143.
28.
MarshDRWongSTMeakinSO: Neutralizing intraspinal nerve growth factor with a trkA—IgG fusion protein blocks the development of autonomic dysreflexia in a clip-compression model of spinal cord injury. J Neurotrauma2002; 19: 1531–1541.
29.
la SalaACorintiSFedericiM: Ligand activation of NGF receptor TrkA protects monocytes from apoptosis. J Leukoc Biol2000; 68: 104–110.
30.
PopovichPGvan RooijenNHickeyWF: Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp Neurol2003; 182: 275–287.
31.
Levi-MontalciniRSkaperSDDal TosoR: Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci1996; 19: 514–520.
32.
TorciaMBracci-LaudieroLLucibelloM: Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell1996; 85: 345–356.
33.
BlanquartCBarbierOFruchartJC: Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol2003; 85: 267–273.
34.
EscherPWahliW: Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res2000; 448: 121–138.
35.
FuenzalidaKMAguileraMCPideritDG: Peroxisome proliferator-activated receptor γ is a novel target of the NGF signaling pathway in PC12 cells. J Biol Chem2005; 280: 9604–9609.
36.
LeypoldBGFlandersAESchwartzED: The impact of methylprednisolone on lesion severity following spinal cord injury. Spine (Phila Pa 1976)2007; 32: 373–378.
37.
PereiraJECostaLMCabritaAM: Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats. Exp Neurol2009; 220: 71–81.
38.
JiangSKhanMIMiddlemissPJ: AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats. Int J Immunopathol Pharmacol2004; 17: 353–366.
39.
SavilleLRPospisilCHMawhinneyLA: A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: A potential neuroprotective treatment. J Neuroimmunol2004; 156: 42–57.
40.
ChvatalSAKimYTBratt-LealAM: Spatial distribution and acute anti-inflammatory effects of methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials2008; 29: 1967–1975.
41.
HayashiMUeyamaTTamakiT: Expression of neurotrophin and IL-1 beta mRNAs following spinal cord injury and the effects of methylprednisolone treatment. Kaibogaku Zasshi1997; 72: 209–213 [in Japanese, English abstract].
42.
TsaiMCWeiCPLeeDY: Inflammatory mediators of cerebrospinal fluid from patients with spinal cord injury. Surg Neurol2008; 70 (suppl 1): 19–24.
43.
ChangCNYangJTLeeTH: Dexamethasone enhances upregulation of nerve growth factor mRNA expression in ischemic rat brain. J Clin Neurosci2005; 12: 680–684.
